CD44 and prostate carcinoma: In the PC3 prostate cancer cell line, CD44 was discovered to carry the mAb F77 (a developed prostate cancer-specific mAb) epitope at the exon 14 region, in which F77 induced apoptosis in this cell line in a CD44-dependent manner.